Get the Stockscreener App
617.15
0.58%
-3.57
After Hours:
617.35
0.20
+0.03%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $617.15, with a volume of 2.40M.
It is down -0.58% in the last 24 hours and up +7.75% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$620.72
Open:
$618.7
24h Volume:
2.40M
Relative Volume:
1.38
Market Cap:
$231.87B
Revenue:
$43.74B
Net Income/Loss:
$6.58B
P/E Ratio:
35.66
EPS:
17.3072
Net Cash Flow:
$6.11B
1W Performance:
+6.51%
1M Performance:
+7.75%
6M Performance:
+47.40%
1Y Performance:
+13.10%
1-Day Range:
$614.72
$626.77
1-Week Range:
$577.00
$628.08
52-Week Range:
$385.46
$628.08
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings - ts2.tech
Thermo Fisher Scientific Builds Hub to Support Local Life Sciences Companies - PHILADELPHIA.Today
The Truth About Thermo Fisher Scientific (TMO): Quiet Lab Giant, Loud Stock Moves - AD HOC NEWS
Thermo Fisher launches obesity registry to track real-world treatment outcomes - drugdiscoverytrends.com
Strategy To YieldBoost Thermo Fisher Scientific To 3.1% Using Options - Nasdaq
Thermo Fisher Scientific (TMO) Valuation Check As New Obesity Registry And Key Updates Draw Investor Focus - Yahoo Finance
Thermo Fisher Scientific to Acquire Clario in $8.875 Billion Deal, Strengthening Digital Clinical Research Capabilities - eHealth Magazine
Bovine Serum Albumin Market to hit US$ 30.89 Billion by 2032 | Top - openPR.com
Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector: Empowering every lab to protect what matters most - Innovation News Network
Is Thermo Fisher (TMO) Using Clario And Margin Focus To Quietly Redefine Its Pharma Toolkit? - simplywall.st
Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus - ts2.tech
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom - ts2.tech
Thermo Fisher Scientific Stock: Quiet Grind Higher Tests Investors’ Patience - AD HOC NEWS
Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst - Benzinga
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Finviz
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - pharmiweb.com
Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - sharewise.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treat - PharmiWeb.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - BioSpace
Robeco Institutional Asset Management B.V. Buys 233,200 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
The Truth About Thermo Fisher Sci.: Why Wall Street Is Quietly Obsessing - AD HOC NEWS
Thermo Fisher Scientific: Quiet Rally Or Calm Before The Next Storm? - AD HOC NEWS
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO - ts2.tech
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week HighShould You Buy? - MarketBeat
Thermo Fisher Scientific stock reaches 52-week high at $610.97 By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific stock reaches 52-week high at $610.97 - Investing.com
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus - ts2.tech
Unpleasant Surprises Could Be In Store For Thermo Fisher Scientific Inc.'s (NYSE:TMO) Shares - simplywall.st
Thermo Fisher Scientific wins three R&D 100 Awards for innovations accelerating drug development - R&D World
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $650 From $610, Maintains Outperform Rating - marketscreener.com
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance
14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
Railway Pension Investments Ltd Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Clinical Trial Supplies Company Evaluation Report 2025: Market Led by Thermo Fisher Scientific, Sharp Services, and Parexel Through End-to-End Capabilities Span Packaging, Logistics, Trial ManagementResearchAndMarkets.com - FinancialContent
Cynosure Group LLC Sells 5,293 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
HD Automatic Colony Counter Market Is Going to Boom |• Thermo Fisher Scientific • Beckman Coulter - openPR.com
Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings - ts2.tech
North Growth Management Ltd. Purchases 6,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by GAM Holding AG - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom - ts2.tech
Synergy Asset Management LLC Has $3.41 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
Altfest L J & Co. Inc. Buys Shares of 5,883 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher stock jumps 2% to start 2026 as investors turn to Jan. 29 earnings - ts2.tech
BofA raises Thermo Fisher (TMO) target as biopharma recovery comes into view - MSN
Bank Pictet & Cie Europe AG Sells 3,510 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
CRISPR Gene Editing Market to Reach US$ 12.78 Billion by 2033 - openPR.com
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):